For many years, this condition was known as Polycystic Ovary Syndrome (PCOS). In May 2026, it was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better represent its wide-ranging effects. Polyendocrine highlights the involvement of multiple hormonal pathways, metabolic reflects its effects on insulin sensitivity, blood sugar and metabolism, while ovarian represents its impact on follicle development, ovulation and fertility. The term syndrome refers to the collection of symptoms associated with the condition, including irregular periods, acne, excess hair growth and weight changes.

How Does PMOS Affect Fertility?

Women with PMOS may experience insulin resistance and hormonal imbalances that interfere with normal follicle development and ovulation. This can result in irregular menstrual cycles, reduced egg quality and difficulty conceiving.

Two naturally occurring forms of inositol: myo-inositol (MYO) and D-chiro-inositol (DCI) are involved in cellular signalling pathways associated with insulin and ovarian function. However, their effectiveness may depend on using them in the appropriate balance.

Introducing Caronositol Fertility®

Caronositol Fertility® is a patented, science-backed combination of myo-inositol (MYO) and D-chiro-inositol (DCI) developed to support women throughout their fertility journey.

It plays an important role in two ways: helping to reduce PMOS symptoms and supporting fertility.

D-Chiro-inositol is a product from Carob bean tree; a Mediterranean tree used for its nutritional and medicinal properties.

The origin of MYO-INOSITOL is natural, it is obtained from the Corn’s Phytin through a process that includes purification.

Myo-inositol supports follicular development and egg quality, while D-chiro-inositol contributes to insulin signalling and hormonal balance. Together, they provide comprehensive support for both reproductive and metabolic health.

However, not all inositol combinations are the same. What truly sets Caronositol Fertility® apart is its ratio.

The Power of the 3.6:1 Ratio

Caronositol Fertility® delivers myo-inositol and D-chiro-inositol in a patented 3.6:1 ratio.

Compared with conventional 40:1 formulations, this precise ratio provides a higher proportion of D-chiro-inositol for more targeted fertility support.

It is not simply about combining two inositols, it is about delivering them in the right balance.

Clinical studies

Studies have demonstrated that Caronositol Fertility® can significantly improve pregnancy rates and reduce the risk of ovarian hyperstimulation syndrome (OHSS) in women with PCOS undergoing fertility treatments, such as intracytoplasmic sperm injection (ICSI).

Contact us to know more about Caronositol Fertility®.